Fermentalg announces signing of distribution agreement for DHA-rich oils and Q3 2017 successes


21 Nov 2017 --- French microalgae specialist Fermentalg has signed a first distribution agreement for algal oils with specialty chemicals and food ingredients company IMCD Group. The news comes as Fermentalg publishes its business review for the third quarter of 2017, with highlights including its strategic partnership with DIC Corporation in pigments and successfully raising €12.6 million (US$14.8 million) in funds as part of a capital increase.

Signing of first distribution agreement for algal oils
The third quarter of 2017 for Fermentalg was marked by the signing of a Europe-wide distribution agreement with IMCD Group, a company that works in the sales, marketing and distribution of specialty chemicals and food ingredients. The agreement includes DHA350, an omega 3-rich algal oil unveiled at Vitafoods Europe, and DHA550, an oil offering a high concentration of omega 3 that is scheduled for launch in the first half of 2018.

Fermentalg notes that its model involves selling its products indirectly through business partners with in-depth knowledge of their markets and considerable sales resources. Several business partnerships are currently being negotiated, the company adds.

Strategic partnership with DIC Corporation in pigments
Fermentalg reports that third-quarter 2017 was also marked by the September 11, 2017 signature of a two-component strategic partnership agreement with Japanese global chemicals company DIC Corporation.

“This alliance will enable us to accelerate our expansion into microalgae-derived natural pigments, our company's second major development focus alongside omega 3 rich oils,” Philippe Lavielle, Chairman and CEO of Fermentalg, said at the time. “This agreement is proof of the effectiveness of Fermentalg's biotechnology platform and of our ability to win over global industry leaders.”

Designed to allow Fermentalg to step up its presence in the health and nutrition market, the partnership includes:

  • A three-year joint development program for two microalgae-derived natural pigments, one of which is phycocyanin (natural blue pigment).
  • A €5 million investment by DIC Corporation in Fermentalg in the form of bonds convertible at €5.00 per share.

The convertible bond issue, which was carried out on October 24, 2017, is primarily intended to finance Fermentalg's R&D activities and its industrial investments, which include the implementation of the joint development agreement.

Stronger financial resources
Also during the period, Fermentalg successfully raised €12.6 million in funds as part of a capital increase with preferential subscription rights maintained, which was 1.6 times oversubscribed.

The increase gives the company the additional means to finance its development, notably through the partnership signed with DIC Corporation, in natural food colorings, nutrition and health.

On September 30, 2017, Fermentalg's gross cash position amounted to €7.5 million (versus €10.2 million at end-June 2017), not including the proceeds from the capital increase or the DIC Corporation convertible bond issue. With these two transactions, the company has secured financing until the first half of 2019.

To contact our editorial team please email us at editorial@cnsmedia.com

Related Articles

Health & Nutrition News

Weekly Roundup: Enzybel Pharma partners with Terhormon on pancreatin, Nuritas forms scientific advisory board

12 Oct 2018 ---- Enzybel Pharma has partnered with Terhormon to “take the lead” on the pancreatin market, while Fermentalg has signed new agreements with the SUEZ group for the development of its algal biofilter. Valensa has adopted saw palmetto through the American Botanical Council’s (ABC) Adopt-an-Herb botanical education program, and the American Herbal Products Association (AHPA) has requested that pullulan be allowed in dietary supplements labeled as organic. VitaMK7, the fermented vitamin K2 as MK7, can offer more than four years of extended stability at room temperature. Research has identified benefits Sabinsa’s Curcumin C3 Complex and BioPerine Combination can bring to diabetics. Nuritas has appointed four key additions to its newly formed scientific advisory board.

Health & Nutrition News

Fermentalg and ADL Biopharma partner on omega 3 supplements

28 Sep 2018 --- Fermentalg, a manufacturer of microalgae for human nutrition and health, and ADL BioPharma are entering a long-term manufacturing contract to produce Fermentalg's algal oil DHA ORIGINS.

Health & Nutrition News

Weekly Roundup: Fermentalg and DSM partner on omega 3, Curcumin gut health benefits

21 Sep 2018 --- The weekly roundup is NutritionInsight's collection of global nutrition stories from the past week. Fermentalg and DSM Nutritional Products entered a five-year commercial agreement for omega 3 products. Research has found that Sabinsa's curcumin products can have a positive effect on gut health, while analysis highlighted the need for more accurate cranberry authentication tools. Mühlenchemie’s Chinese production facility has been certified to supply fortified foods to the UN World Food Programme.

Business News

Fermentalg reports on Q1 revenue as US expansion begins

20 Apr 2018 --- Fermentalg, a French supplier of microalgae for nutrition and health, has reported first-quarter revenue of €232k whereas no income was recorded in Q1 2017. As of 31 March 2018, Fermentalg held gross cash and cash equivalents of €19.5 million compared to €21.8 million at 31 December 2017. Cash burn amounted to a €2.5 million outflow, stable compared to the previous quarter (excluding financing activities) and down €0.5 million from Q1 2017. Q1 was marked by progress achieved in bringing to market its DHA ORIGINS range of algal oils naturally rich in omega 3, as well as a US distribution agreement with Stauber, a leading North American supplier of specialty ingredients, the company reports. 

Health & Nutrition News

Fermentalg DHA range to enter US market under new partnership

03 Apr 2018 --- French microalgae supplier Fermentalg has obtained Generally Recognized As Safe (GRAS) status for its algal oils which are “naturally rich in omega 3” and they have signed a distribution agreement with Stauber for the US and Canada. These steps represent Fermentalg’ success in driving its DHA origins range on the US market.

More Articles
URL : http://www.nutritioninsight.com:80/news/fermentalg-announces-signing-of-distribution-agreement-for-dha-rich-oils-and-q3-2017-successes.html